Clinical Trials Directory

Trials / Completed

CompletedNCT03917953

Transcutaneous Electrical Acupoint Stimulation for the Treatment of ADHD

Transcutaneous Electrical Acupoint Stimulation for Treating Attention Deficit Hyperactivity Disorder: A Prospective, Randomized, Controlled Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
78 (actual)
Sponsor
First Affiliated Hospital Xi'an Jiaotong University · Academic / Other
Sex
All
Age
6 Years – 12 Years
Healthy volunteers
Not accepted

Summary

RATIONALE: Transcutaneous electrical acupoint stimulation may improve attention deficit hyperactivity disorder (ADHD). PURPOSE: This randomized-controlled trial study of treating attention deficit hyperactivity disorder of school-aged children with transcutaneous electrical acupoint stimulation to see how well it works compared to sham transcutaneous electrical acupoint stimulation.

Detailed description

OBJECTIVES: Primary To determine whether true transcutaneous electrical acupoint stimulation(TEAS) administered twice weekly for 4 weeks (8 sessions) compared to sham TEAS causes a significant improvement in symptoms of ADHD according to the investigator-rated Clinical Global Impression-Improvement (CGI-I) scores at week 4. Secondary To evaluate the changes from baseline to week 4 of Clinical Global Impressions Scale-Severity of Illness (CGI-S),Conners'Parent Rating Scales-Revised: Short Form (CPRS-R: S) score, Conners'Teacher Rating Scales-Revised: Short Form (CTRS-R: S) score, go/no-go task performances, and the concentration of oxygenated hemoglobin within the prefrontal cortex. OUTLINE: This is a single-center study. Patients are randomized to two treatment arms. Arm I: Patients receive TEAS twice weekly for 4 weeks . Arm II: Patients receive sham TEAS twice weekly for 4 weeks .

Conditions

Interventions

TypeNameDescription
DEVICETranscutaneous Electrical Acupoint StimulationPatients in the experimental group will be treated for 20 min TEAS, twice a week, for a total of 4 weeks of treatment.The same intervention was performed in the sham group (electrode patches were attached at corresponding acupoints without electrical stimulation). Acupoint selection: baihui (GV 20), taichong (LR 3), taixi (KI 3).

Timeline

Start date
2019-07-01
Primary completion
2019-12-01
Completion
2020-01-17
First posted
2019-04-17
Last updated
2021-03-15

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03917953. Inclusion in this directory is not an endorsement.